Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

67.05USD
24 Apr 2017
Change (% chg)

$0.62 (+0.93%)
Prev Close
$66.43
Open
$67.18
Day's High
$67.74
Day's Low
$65.66
Volume
487,090
Avg. Vol
452,859
52-wk High
$111.00
52-wk Low
$65.49

Latest Key Developments (Source: Significant Developments)

Perrigo completes divestiture of tysabri royalty stream for up to $2.85 billion
Monday, 27 Mar 2017 04:01pm EDT 

Perrigo Company Plc :Perrigo completes divestiture of Tysabri® royalty stream for up to $2.85 billion.  Full Article

Perrigo announced first-to-market launch of OTC store brand equivalent to women's Rogaine foam
Wednesday, 8 Mar 2017 08:35am EST 

Perrigo Company Plc :Perrigo Company Plc- announced first-to-market launch of over--counter store brand equivalent to women's Rogaine foam.  Full Article

Perrigo says in process of identifying certain deferred tax assets, other related effects at Omega Pharma Invest N.V
Tuesday, 7 Mar 2017 04:03pm EST 

Perrigo Company Plc : Perrigo provides 2016 form 10-k update . Perrigo provides 2016 form 10-k update . Perrigo Company Plc - in process of identifying certain deferred tax assets and other related effects at Omega Pharma Invest N.V. .Perrigo Company Plc - is in a quiet period regarding financial matters until March 16, 2017, filing due date under extension.  Full Article

Perrigo announces FDA final approval for the generic version of Axiron topical solution
Wednesday, 1 Mar 2017 08:55am EST 

Perrigo Company Plc :Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml.  Full Article

Perrigo Company expects to reduce its workforce by about 750 employees
Monday, 27 Feb 2017 05:20pm EST 

Perrigo Company Plc : Perrigo Company Plc - company expects to reduce its global workforce by approximately 750 employees . Perrigo Company Plc- represents a reduction of approximately 14 pct of company's global non-production workforce . Perrigo Company Plc - company anticipates recognizing substantially all of charges by end of fiscal 2017 . Perrigo Company Plc - on Feb. 21, 2017, company approved a workforce reduction plan . Perrigo Company - estimates that it will recognize total pre-tax restructuring charges to its GAAP financial results of approximately $70-80 million .Perrigo - global workforce reduction includes some actions already taken, 243 employees who have elected for voluntary early retirement program.  Full Article

Perrigo Company Plc files for non-timely 10-Q
Monday, 27 Feb 2017 04:57pm EST 

Perrigo Company Plc : Perrigo Company Plc files for non-timely 10-Q . Files for non-timely 10-Q - SEC Filing . Perrigo Company Plc - Is in the process of identifying certain deferred tax assets and other related effects at Omega Pharma Invest N.V. . Perrigo Company Plc - Company has not completed its calculation of the implied fair value of the Tysabri asset . Perrigo Company says it has not completed its calculation of the implied fair value of the Tysabri asset .Perrigo Company says its independent auditors also are evaluating the historical revenue recognition practices associated with Tysabri.  Full Article

Perrigo Company Plc sees FY 2017 sales $5 bln to $5.2 bln
Monday, 27 Feb 2017 04:05pm EST 

Perrigo Company Plc : FY2017 earnings per share view $7.10, revenue view $5.44 billion -- Thomson Reuters I/B/E/S . Currently expects to file form 10-K on or before March 16, 2017 . Perrigo Company Plc reports select preliminary unaudited calendar year 2016 financial results and initial calendar year 2017 guidance . Sees FY 2017 sales $5.0 billion to $5.2 billion . Sees FY 2017 adjusted earnings per share $6.30 to $6.65 . Sees FY 2017 earnings per share $3.39 to $3.74 .Perrigo Company - Announces streamlining of organizational structure, which is expected to yield greater than $130 million savings per annum by mid-2018.  Full Article

Perrigo signs agreement to divest tysabri royalty stream for up to $2.85 billion
Monday, 27 Feb 2017 04:03pm EST 

Perrigo Company Plc : Perrigo signs agreement to divest tysabri® royalty stream for up to $2.85 billion . Perrigo signs agreement to divest tysabri® royalty stream for up to $2.85 billion . Perrigo company plc - deal includes up to $650 million in potential milestone payments based upon future global net sales of tysabri in 2018 and 2020 . Perrigo company plc - transaction is valued at a total consideration of up to $2.85 billion, including $2.2 billion in cash . Perrigo company - royalty pharma will acquire all of perrigo's rights to receive tysabri(® )royalty payments from and after january 1, 2017 . Perrigo company - says royalty pharma will acquire all of perrigo's rights to receive tysabri royalty payments from and after january 1, 2017 . Perrigo company plc - perrigo will also assign to royalty pharma certain information and audit rights under perrigo's existing agreement with biogen . Perrigo - royalty pharma to pay additional payments of $250 million if royalties earned on global sales of tysabri meet specified thresholds during 2018 .Perrigo company- royalty pharma to pay additional payments of $400 million if royalties earned on global net sales of tysabri meet specified thresholds in 2020.  Full Article

Perrigo says Ron Winowiecki appointed acting CFO
Monday, 27 Feb 2017 04:01pm EST 

Perrigo Company Plc : Perrigo announces leadership changes . Says Ron Winowiecki appointed acting CFO . Is conducting a thorough search process to identify a permanent Chief Financial Officer, which includes Mr. Winowiecki as a key candidate . Perrigo Company Plc- Is conducting a thorough search process to identify a permanent Chief Financial Officer .Perrigo Company Plc- Resignation of Judy L. Brown, executive Vice President, business operations and Chief Financial Officer.  Full Article

Perrigo sets quarterly dividend of $0.16 per share
Tuesday, 21 Feb 2017 11:34am EST 

Perrigo Company Plc :Sets quarterly dividend of $0.16 per share.  Full Article

More From Around the Web

BRIEF-Perrigo completes divestiture of tysabri royalty stream for up to $2.85 billion

* Perrigo completes divestiture of Tysabri® royalty stream for up to $2.85 billion Source text for Eikon: Further company coverage: